Colorectal Cancer Archive

A 2022 study led to questions regarding whether colonoscopy is the best strategy to reduce the risk of death from colon cancer. But overwhelming evidence supports the procedure for lowering the risk of colon cancer and related death, and experts continue to recommend people at average risk get at least one colonoscopy beginning at age 45.

Groundbreaking cancer treatments continuously emerge from labs and research trials. Three Harvard oncologists share what stands out in their respective fields of prostate, lung, and colon cancer, the most common cancers among men. Examples include greater roles for immunotherapy, targeted therapy, and intensive hormonal treatments.

Colorectal cancer is the second most common cause of cancer death among Americans. A recent study raised questions about the value of screening colonoscopy, which can identify and remove precancerous growths, and our experts weigh in with answers.

Left-handers make up only 10% of the population. Despite some common beliefs, science has yet to show that left-handers have any specific advantages or disadvantages over right-handed people in terms of physical abilities, cognitive health, or longevity.

A 2022 study found that women who begin colorectal cancer screening at age 45 with colonoscopy or sigmoidoscopy are far less likely to develop the disease than women who don't undergo any screening or who start screening at age 50.

A 2022 study suggests that eating meat (including poultry) fewer than five times a week may protect people from cancer. Consuming only fish and no meat or following a vegetarian or vegan diet may offer even greater protection.

Colorectal cancer is the second leading cause of cancer deaths in the United States, and rates are rising, particularly in younger people. It can be prevented with screening tests; there are several different types of tests that are performed in different ways, and guidelines for when testing should begin and how often people should be tested.

There are several at-home screening tests for colorectal cancer. The most accurate are a fecal immunochemical test (FIT) and a multitarget stool DNA (mt-sDNA) test (Cologuard), also known as a FIT-DNA test. The FIT test uses antibodies to detect blood in stool, and must be done once a year. The FIT-DNA test can identify DNA from cancer cells in the stool and also has a FIT component to look for blood. This test may be repeated once every three years.

Scary or misleading claims about things that may cause cancer are so plentiful that it's hard to know which ones to take seriously. A new website developed by experts aims to provide reliable information about whether a particular cancer claim is true.